Ethema Health Corp (GRST)

[Bubae]

It is time to get back into this because it should get interesting soon. Starting to review my old posts that we know is chocked full of actual due diligence on this ticker. 😆 The $150K Bauman note became eligible in February with the ...subject to anti-dilution provisions of course. We have another note that matured March 15 for a principal amount of $250,000. Interesting, I guess share holders no longer are allowed to see the details for these two notes? I see no such filing. No details at all concerning the nature of the $250K note.


Bubae
Re: None
Sunday, November 26, 2023 5:35:15 AM
Post# 49291 of 49803
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173295585

Even after acquiring the cash from the crazy lease finance deal to pay a bit more than $2 million on the defaulted debt they still borrowed an additional $720K in Q3 and up to November 15th. They boasted about retiring the convertible notes in the July 17th press release and then turn right around and write a new one for $150K on August 9th.

For the quarterly period ended September 30, 2023
https://www.sec.gov/ix?doc=/Archives/edgar/data/0000792935/000190359623000912/grst_10q.htm

8. Short-term Convertible Notes (continued)
Joshua Bauman

On August 9, 2023, the Company issued a convertible promissory note to Bauman, in the aggregate principal amount of $150,000. The note bears interest at 10.0% per annum and matures on August 9, 2024. The note is convertible into shares of common stock at a conversion price at the option of the holder at $0.001 per share, adjusted for anti-dilution provisions. The note is convertible into common stock at the option of the holder after the expiration of six months from the issuance date, in addition, should the note reach its maturity date, August 9, 2024, the note will automatically convert into shares of common stock at the conversion price, subject to anti-dilution provisions.

9. Subsequent events

On November 15, 2023, the Company, entered into a senior secured Promissory Note in the aggregate principal amount of $250,000 for net proceeds of $223,500 after an original issue discount and fees of $26,500. The note earns interest at 10% per annum and matures on March 15, 2024.